We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

A human embryonic stem cell-derived clonal progenitor cell line with chondrogenic potential and markers of craniofacial mesenchyme

    Hal Sternberg

    BioTime, Inc., Alameda, CA 94502, USA

    ,
    James T Murai

    BioTime, Inc., Alameda, CA 94502, USA

    ,
    Isaac E Erickson

    BioTime, Inc., Alameda, CA 94502, USA

    ,
    Walter D Funk

    BioTime, Inc., Alameda, CA 94502, USA

    ,
    Shreyasi Das

    Burnham–Sanford Medical Research Institute, La Jolla, CA 92037, USA

    ,
    Qian Wang

    Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA 94305, USA

    ,
    Evan Snyder

    Burnham–Sanford Medical Research Institute, La Jolla, CA 92037, USA

    ,
    Karen B Chapman

    BioTime, Inc., Alameda, CA 94502, USA

    ,
    C Thomas Vangsness

    Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA

    &
    Published Online:https://doi.org/10.2217/rme.12.29

    Aims: We screened 100 diverse human embryonic stem-derived progenitor cell lines to identify novel lines with chondrogenic potential. Materials & methods: The 4D20.8 cell line was compared with mesenchymal stem cells and dental pulp stem cells by assessing osteochondral markers using immunohistochemical methods, gene expression microarrays, quantitative real-time PCR and in vivo repair of rat articular condyles. Results: 4D20.8 expressed the site-specific gene markers LHX8 and BARX1 and robustly upregulated chondrocyte markers upon differentiation. Differentiated 4D20.8 cells expressed relatively low levels of COL10A1 and lacked IHH and CD74 expression. Transplantation of 4D20.8 cells into experimentally induced defects in the femoral condyle of athymic rats resulted in cartilage and bone differentiation approximating that of the original tissue architecture. Relatively high COL2A1 and minimal COL10A1 expression occurred during differentiation in HyStem-C hydrogel with TGF-β3 and GDF-5. Conclusion: Human embryonic stem cell-derived embryonic progenitor cell lines may provide a novel means of generating purified site-specific osteochondral progenitor cell lines that are useful in research and therapy.

    Original submitted 6 March 2012; Revised submitted 5 April 2012; Published online 23 April 2012

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References

    • Khan WS, Johnson DS, Hardingham TE. The potential of stem cells in the treatment of knee cartilage defects. Knee17,369–374 (2010).▪ Recent review on treatment modalities, including the use of cell-based formulations for the treatment of orthopedic disorders involving knee cartilage.
    • Gao J, Yao JQ, Caplan AI. Stem cells for tissue engineering of articular cartilage. Proc. Inst. Mech. Eng. H221,441–450 (2007).
    • Toh WS, Yang Z, Liu H, Heng BC, Lee EH, Cao T. Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells25,950–960 (2007).
    • Jakob M, Démarteau O, Schäfer D et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell. Biochem.81,368–377 (2001).
    • Grande DA, Pitman MI, Peterson L, Menche D, Klein M. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J. Orthop. Res.7,208–218 (1989).
    • Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med.331,889–895 (1994).
    • Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res.238,265–272 (1998).▪ Original description of methods to induce chondrogenic differentiation in cells through high-density micromass culture.
    • Akiyama H, Kim JE, Nakashima K et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl Acad. Sci. USA102,14665–14670 (2005).
    • Sekiya I, Tsuji K, Koopman P et al.SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem.275,10738–10744 (2000).
    • 10  Pelttari K, Winter A, Steck E et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum.54,3254–3266 (2006).
    • 11  Gebhard S, Hattori T, Bauer E et al. BAC constructs in transgenic reporter mouse lines control efficient and specific LacZ expression in hypertrophic chondrocytes under the complete Col10a1 promoter. Histochem. Cell Biol.127,183–194 (2007).▪ Reports the expression of COL10A1 in the mouse in regions of hypertrophy such as growth plates.
    • 12  Mak KK, Kronenberg HM, Chuang PT, Mackem S, Yang Y. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development135,1947–1956 (2008).
    • 13  Topping RE, Bolander ME, Balian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clin. Orthop. Relat. Res.308,220–228 (1994).
    • 14  Grant WT, Wang GJ, Balian G. Type X collagen synthesis during endochondral ossification in fracture repair. J. Biol. Chem.262,9844–9849 (1987).
    • 15  Ganss B, Kim RH, Sodek J. Bone sialoprotein Crit. Rev. Oral Biol. Med.10,79–98 (1999).
    • 16  Hiraki Y, Inoue H, Iyama K et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem.272,32419–32426 (1997).
    • 17  Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science282,1145–1147 (1998).
    • 18  Heng BC, Cao T, Lee EH. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells22,1152–1167 (2004).
    • 19  Toh WS, Lee EH, Guo XM et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials31,6968–6980 (2010).
    • 20  Steck E, Benz K, Lorenz H et al. Chondrocyte expressed protein-68 (CEP-68), a novel human marker gene for cultured chondrocytes. Biochem. J.353,169–174 (2001).▪ Characterizes the CRTAC1 gene as a molecular marker of definitive as opposed to hypertrophic chondrocytes.
    • 21  Benz K, Breit S, Lukoschek M, Mau H, Richter W. Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem. Biophys. Res. Commun.293,284–292 (2002).
    • 22  West MD, Sargent RG, Long J et al. The ACTCellerate Initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives. Regen. Med.3,287–308 (2008).▪▪ Describes the first large-scale isolation of human clonal embryonic progenitor cell lines, methods of their derivation and microarray-based gene expression profiles.
    • 23  Grigoriou M, Tucker AS, Sharpe PT, Pachnis V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development125,2063–2074 (1998).
    • 24  Zhao Y, Guo Y-J, Tomac AC et al. Isolated cleft palate in mice with a targeted mutation of the LIM homeobox gene lhx8. Proc. Natl Acad. Sci. USA96,15002–15006 (1999).
    • 25  Zhang Y, Mori T, Takaki H et al. Comparison of the expression patterns of two LIM-homeodomain genes, Lhx6 and L3/Lhx8, in the developing palate. Orthod. Craniofac. Res.5,65–70 (2002).▪ Characterizes the regional expression pattern of LHX8 in the craniofacial mesenchyme of the developing mouse.
    • 26  Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA97,13625–13630 (2000).
    • 27  Vilmann H. The in vivo staining of bone with Alizarin Red S. J. Anat.105,533–545 (1969).
    • 28  Proia AD, Brinn NT. Identification of calcium oxalate crystals using Alizarin Red S stain. Arch. Pathol. Lab. Med.109,186–189 (1985).
    • 29  Krause U, Seckinger A, Gregory CA. Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods Mol. Biol.698,215–230 (2011).
    • 30  Rosenberg L. Chemical basis for the histological use of Safranin O in the study of articular cartilage. J. Bone Joint Surg.53,69–82 (1971).
    • 31  Mauck RL, Yuan X, Tuan RS. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage14,179–189 (2006).
    • 32  Park S, Hung CT, Ateshian GA. Mechanical response of bovine articular cartilage under dynamic unconfined compression loading at physiological stress levels. Osteoarthritis Cartilage12,65–73 (2004).
    • 33  Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod. Rheumtol.18,213–219 (2008).
    • 34  Akiyama H, Lefebvre V. Unraveling the transcriptional regulatory machinery in chondrogenesis. J. Bone Miner. Metab.29,390–395 (2011).
    • 35  Ishii M, Koike C, Igarashi A et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem. Biophys. Res. Commun.332,297–303 (2005).
    • 36  Kumar S, Hand AT, Connor JR et al. Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J. Biol. Chem.274,17123–17131 (1999).
    • 37  Jones JA, Gray MR, Oliveira BE, Koch M, Castellot JJ Jr. CCN5 expression in mammals: I. Embryonic and fetal tissues of mouse and human. J. Cell Commun. Signal.1,127–143 (2007).
    • 38  Kato T, Ito T, Imatani T, Minaguchi K, Saitoh E, Okuda K. Cystatin SA, a cysteine proteinase inhibitor, induces interferon-gamma expression in CD4-positive T cells. Biol. Chem.385,419–422 (2004).
    • 39  Yanagita M, Kashiwagi Y, Kobayashi R, Tomoeda M, Shimabukuro Y, Murakami S. Nicotine inhibits mineralization of human dental pulp cells. J. Endod.34,1061–1065 (2008).
    • 40  Shibaguchi T, Kato J, Abe M et al. Expression and role of Lhx8 in murine tooth development. Arch. Histol. Cytol.66,95–108 (2003).
    • 41  Tissier-Seta JP, Mucchielli ML, Mark M, Mattei MG, Goridis C, Brunet JF. Barx1, a new mouse homeodomain transcription factor expressed in cranio–facial ectomesenchyme and the stomach. Mech. Dev.51,3–15 (1995).▪ Describes the characterization of the BARX1 homeobox gene and regional expression in the developing craniofacial mesenchyme of the developing mouse.
    • 42  Tucker AS, Matthews KL, Sharpe PT. Transformation of tooth type induced by inhibition of BMP signaling. Science282,1136–1138 (1998).
    • 43  Nie X. Developmentally regulated expression of MSX1, MSX2 and Fgfs in the developing mouse cranial base. Angle Orthod.76,990–995 (2006).
    • 44  Clouthier DE, Williams SC, Yanagisawa H, Wieduwilt M, Richardson JA, Yanagisawa M. Signaling pathways crucial for craniofacial development revealed by endothelin-A receptor-deficient mice. Dev. Biol.217,10–24 (2000).
    • 45  Kim J, Lo L, Dormand E, Anderson DJ. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron38,17–31 (2003).
    • 46  Acampora D, Merlo GR, Paleari L et al. Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development126,3795–3809 (1999).▪ Demonstrates the site-specific expression of DLX5 in the branchial arches during early embryonic development and the progressive expansion of the gene over the course of development.
    • 47  Anderson DJ. Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu. Rev. Neurosci.16,129–158 (1993).
    • 48  Draper JS, Smith K, Gokhale P et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol.22,53–54 (2004).
    • 49  Fukiishi Y, Morriss-Kay GM. Migration of cranial neural crest cells to the pharyngeal arches and heart in rat embryos. Cell Tissue Res.268,1–8 (1992).
    • 50  Imai H, Osumi-Yamashita N, Ninomiya Y, Eto K. Contribution of early-emigrating midbrain crest cells to the dental mesenchyme of mandibular molar teeth in rat embryos. Dev. Biol.176,151–165 (1996).
    • 51  Noden DM. The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev. Biol.96,144–165 (1983).
    • 52  Takahashi K, Nuckolls GH, Takahashi I et al.Msx2 is a repressor of chondrogenic differentiation in migratory cranial neural crest cells. Dev. Dyn.222,252–262 (2001).
    • 53  Chai Y, Jiang X, Ito Y et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development127,1671–1679 (2000).
    • 54  Jeong J, Mao J, Tenzen T, Kottmann AH, McMahon AP. Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev.18,937–951 (2004).
    • 55  Kim JY, Jeon SH, Park JY, Suh JD, Choung PH. Comparative study of LHX8 expression between odontoma and dental tissue-derived stem cells. J. Oral Pathol. Med.40,250–256 (2011).
    • 56  Yamada Y, Fujimoto A, Ito A, Yoshimi R, Ueda M. Cluster analysis and gene expression profiles: a cDNA microarray system-based comparison between human dental pulp stem cells (hDPSCs) and human mesenchymal stem cells (hMSCs) for tissue engineering cell therapy. Biomaterials27,3766–3781 (2006).
    • 57  Hinoi E, Bialek P, Chen Y-T et al. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev.20,2937–2942 (2006).
    • 58  Liu Z, Xu J, Colvin JS, Ornitz DM. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev.16,859–869 (2002).
    • 59  Ohbayashi N, Shibayama M, Kurotaki Y et al.FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev.16,870–879 (2002).
    • 60  Cormier S, Leroy C, Delezoide AL, Silve C. Expression of fibroblast growth factors 18 and 23 during human embryonic and fetal development. Gene Expr. Patterns5,569–573 (2005).
    • 61  Bian L, Zhai DY, Zhang EC, Mauck RL, Burdick JA. Dynamic compressive loading enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng. Part A18,715–724 (2012).
    • 62  Bian L, Zhai DY, Mauck RL, Burdick JA. Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. Tissue Eng. Part A17,1137–1145 (2011).
    • 63  Bahney CS, Hsu CW, Yo, JU, West JL, Johnstone B. A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J.25,1486–1496 (2011).